Ειδήσεις: BIOTECH INVESTMENT | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

30/03 17:00 entrepreneur.com

Pharma Giant Eli Lilly Is Paying $2.75 Billion for Drugs Designed by AI – Here’s What It Gets Them

Eli Lilly AI drug design pharmaceutical acquisition research acceleration biotech investment drug development

29/03 23:50 yahoo.com

Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab

UBS Jasper Therapeutics neutral valuation Briquilimab C biotech investment pipeline potential

28/03 10:30 defenseworld.net

Generali Investments CEE investicni spolecnost a.s. Purchases 4,797 Shares of Biogen Inc. $BIIB

Generali Investments Biogen Inc 13F filing Q4 holdings Advisory Services Network biotech investment

27/03 16:19 yahoo.com

Do Protagonist Therapeutics’ (PTGX) Derisked Drugs Have Blockbuster Potential?

Protagonist Therapeutics PTGX derisked drugs blockbuster potential pharmaceutical pipeline market dynamics

26/03 13:58 fortune.com

America is handing its mRNA lead to China—and RFK Jr. is to blame

political interference biotech investment mRNA technology China RFK Jr.U.S. patients

26/03 04:33 yahoo.com

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Pfizer prostate cancer stock price 2-to-1 payoff oncology trial analyst outlook

18/03 16:13 yahoo.com

Why Ionis Pharmaceuticals’ (IONS) 2026 Catalyst Pipeline Supported Leerink’s Higher Target

Ionis Pharmaceuticals Catalyst pipeline Leerink 2026 outlook RNA therapeutics revenue growth

17/03 16:05 yahoo.com

Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now?

Crispr Therapeutics gene editing stock analysis biotech investment CRISPR valuation

17/03 09:29 defenseworld.net

Boothbay Fund Management LLC Purchases 42,687 Shares of Avidity Biosciences, Inc. $RNA

Avidity Biosciences Boothbay Fund AlphaQuest biotech investment share purchase Q3 holdings

17/03 09:29 defenseworld.net

Boothbay Fund Management LLC Purchases 42,687 Shares of Avidity Biosciences, Inc. $RNA

Avidity Biosciences Boothbay Fund AlphaQuest biotech investment share purchase Q3 holdings

Loading...